Lebesil is used to normalize liver and gall bladder function in the following cases: chronic inflammatory diseases of the gallbladder and liver; biliary dyskinesia; postcholecystectomy syndrome; toxic hepatitis (including alcohol); atherosclerosis, obesity; chronic nephritis, chronic renal failure; hepatomegaly in congestive heart failure; in the complex treatment of mastopathy, diabetes, thyroid disease
Dry extract of milk thistle (Silybium Marianum) – 50 mg.
Dry extract of Spanish artichoke leaves (Cynarascolymus) – 50 mg.
Dry extract of the root of turmeric long (Curcumalonga) – 24.8 mg.
Micronized Turmeric Powder (Curcumalonga) 24.8 mg
Dry extract of dandelion root (Taraxacumofficinalis) – 37.2 mg.
Dry extract of leaves of medicinal rosemary (Rosmarinusofficinalis) – 18.6 mg.
Dry extract of the tops of St. John’s wort (Hypericumperforatum) – 5.27 mg.
Dry extract of lemon balm (Melissaofficinalis) – 29.7 mg.
Dry extract of Bold leaves (Peumusboldus) – 17.05 mg.
Dry extract of birch leaves (Betulaalba) – 15.5 mg.
Dry extract of Cornella (Angelicaarchangelica) – 10.85 mg.
Filler cellulose microcrystalline anticummer silicon dioxide, magnesium stearate.
The drug normalizes the bile function of the liver, reduces the tone of the sphincter of Oddi, facilitates the flow of bile into the intestines.
Combined choleretic drug of plant origin with hepatoprotective action. The components that make up the drug exhibit choleretic, anti-inflammatory, antispasmodic and hepatoprotective effects, and also increase the ability of hepatocytes to produce coenzymes, which improves the metabolism of cholesterol, lipids and the metabolism of ketone bodies. With concomitant antibiotic therapy, it acts on the parenchyma of the kidneys and liver as a detoxification agent. Milk thistle has a hepatoprotective effect: it exhibits antitoxic, antioxidant, membrane stabilizing, cytoprotective effect, promotes the regeneration of hepatocytes.
Lebesil is used to normalize the function of the liver and gallbladder, as well as for:
chronic inflammatory diseases of the gallbladder and liver;
dyskinesia of the biliary tract;
toxic hepatitis (including alcoholic);
chronic nephritis, chronic renal failure;
hepatomegaly with congestive heart failure;
complex treatment of mastopathy, diabetes mellitus, thyroid disease.
Individual intolerance to the components of the drug, cholecystitis, liver cirrhosis, epilepsy, children under 6 years of age, pregnancy and lactation.
Lebesil Method of administration and dosage
Depends on the pathology, 1 capsule 1-2 times a day, preferably before or after meals. The course of treatment is 15-30 days.
3 years from the date of manufacture.
Store at a temperature not exceeding 25 ° C, in its original packaging, out of the reach of children.
45 capsules per pack.